Federal Register / Vol. 75, No. 238 / Monday, December 13, 2010 / Notices 77645 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Pregnancy 

Risk Assessment Monitoring System 

(PRAMS), DP11–001 Panel E, Initial 

Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 10 a.m.–5 p.m., March 8, 

2011 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters To Be Discussed: The meeting will 

include the initial review, discussion, and 

evaluation of ‘‘Pregnancy Risk Assessment 

Monitoring System (PRAMS), DP11–001 

Panel E.’’ 

Contact Person for More Information: 

Donald Blackman, Ph.D., Scientific Review 

Officer, CDC, National Center for Chronic 

Disease Prevention and Health Promotion, 

Office of the Director, Extramural Research 

Program Office, 4770 Buford Highway, NE., 

Mailstop K–92, Atlanta, GA 30341, 

Telephone: (770) 488–3023, e-mail: 

DBY7@cdc.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: December 2, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–31147 Filed 12–10–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Pregnancy 

Risk Assessment Monitoring System 

(PRAMS), DP11–001 Panel F, Initial 

Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 9 a.m.–6 p.m., March 4, 

2011 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters to be Discussed: The meeting will 

include the initial review, discussion, and 

evaluation of ‘‘Pregnancy Risk Assessment 

Monitoring System (PRAMS), DP11–001 

Panel F.’’ 

Contact Person for More Information: 

Donald Blackman, PhD, Scientific Review 

Officer, CDC, National Center for Chronic 

Disease Prevention and Health Promotion, 

Office of the Director, Extramural Research 

Program Office, 4770 Buford Highway, NE., 

Mailstop K–92, Atlanta, GA 30341, 

Telephone: (770) 488–3023, e-mail: 

DBY7@cdc.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: December 2, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–31146 Filed 12–10–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Pregnancy 

Risk Assessment Monitoring System 

(PRAMS), DP11–001 Panel D, Initial 

Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 11 a.m.–3 p.m., February 

25, 2011 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters to be Discussed: The meeting will 

include the initial review, discussion, and 

evaluation of ‘‘Pregnancy Risk Assessment 

Monitoring System (PRAMS), DP11–001 

Panel D.’’ 

Contact Person for More Information: 

Donald Blackman, Ph.D., Scientific Review 

Officer, CDC, National Center for Chronic 

Disease Prevention and Health Promotion, 

Office of the Director, Extramural Research 

Program Office, 4770 Buford Highway, NE., 

Mailstop K–92, Atlanta, GA 30341, 

Telephone: (770) 488–3023, e-mail: 

DBY7@cdc.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: December 2, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–31143 Filed 12–10–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2010–N–0622] 

Agency Information Collection 

Activities; Proposed Collection; 

Comment Request; Color Additive 

Certification Requests and 

Recordkeeping 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing an 

opportunity for public comment on the 

proposed collection of certain 

information by the Agency. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), Federal Agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension of an existing collection of 

information, and to allow 60 days for 

public comment in response to the 

notice. This notice solicits comments on 

the information collection provisions of 

FDA’s regulations governing batch 

certification of color additives 

manufactured for use in foods, drugs, 

cosmetics or medical devices in the 

United States. 

DATES: Submit either electronic or 

written comments on the collection of 

information by February 11, 2011. 

ADDRESSES: Submit electronic 

comments on the collection of 

information to http:// 


wwoods2 on DSK1DXX6B1PROD with NOTICES_PART 1